220100 퓨쳐켐
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 2,186억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 방사성의약품 · 핵의학 · 알츠하이머진단 · 파킨슨진단 · 바이오
- 네이버 금융: 🔗
기업개요
- 동사는 2001년 설립된 방사성의약품 신약 개발 기업으로 2015년 코넥스 상장 후 2016년 코스닥 이전상장함.
- ㈜퓨쳐켐헬스케어, ㈜에스아이헬스케어 등 계열사와 협력하여 신약 개발과 의료기기 유통, 글로벌 임상 관리를 운영하고 있음.
- 주력 사업은 특정 질병의 특이 단백질에 방사성동위원소를 결합해 진단·치료하는 방사성의약품 개발이며, 알츠하이머 진단제 알자뷰, 파킨슨 진단제 피디뷰, 전립선암 진단제 FC303 등을 보유하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 8,690 | 8,510 | 🔵 -2.07% | +0.81%p | ×0.5 | 🔻 개인 | -0.7억 | -0.3 | +0.0 | -0.0 | -0.4 | +0.8 | +0.0 |
| 2026-08-13 | 8,990 | 8,690 | 🔵 -3.34% | +0.22%p | ×0.6 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | -0.6 | +0.0 | +1.4 | +0.1 |
| 2026-08-12 | 9,070 | 8,990 | 🔵 -0.88% | +0.77%p | ×5.9 | 🟡 금투 | -1.0억 | -1.0 | +0.0 | +15.2 | +0.0 | -14.2 | +0.1 |
| 2026-08-11 | 9,180 | 9,070 | 🔵 -1.20% | +0.00%p | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.3 | -0.2 |
| 2026-08-10 | 8,710 | 9,180 | 🔴 +5.40% | +0.69%p | ×1.1 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | +0.0 | -0.6 | -0.0 |
| 2026-08-07 | 8,890 | 8,710 | 🔵 -2.02% | -0.67%p | ×0.7 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.0 | +0.0 | +1.1 | +0.0 |
| 2026-08-06 | 8,930 | 8,890 | 🔵 -0.45% | +1.12%p | ×0.7 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.0 | +0.7 | +0.2 |
| 2026-08-05 | 9,060 | 8,930 | 🔵 -1.43% | -0.33%p | ×1.0 | 🔻 개인 | -1.9억 | -1.9 | +0.0 | +0.0 | +0.0 | +1.8 | +0.0 |
| 2026-08-04 | 7,830 | 9,060 | 🔴 +15.71% | +0.64%p | ×1.9 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.0 | +0.0 | +0.6 | -0.0 |
| 2026-08-03 | 7,600 | 7,830 | 🔴 +3.03% | -1.58%p | ×0.8 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | +0.0 | +0.0 | +1.0 | -0.1 |
| 2026-07-31 | 6,640 | 7,600 | 🔴 +14.46% | -0.30%p | ×0.9 | 🟢 외인 | +2.1억 | +2.1 | +0.0 | +0.0 | +0.0 | -2.0 | -0.1 |
| 2026-07-30 | 6,710 | 6,640 | 🔵 -1.04% | -4.02%p | ×0.8 | 🟢 외인 | +0.8억 | +1.2 | +0.0 | +0.0 | -0.4 | -0.8 | +0.0 |
| 2026-07-29 | 7,430 | 6,710 | 🔵 -9.69% | -2.83%p | ×1.2 | 🔻 개인 | -1.7억 | -1.7 | +0.0 | -0.1 | +0.0 | +1.7 | +0.0 |
| 2026-07-28 | 7,900 | 7,430 | 🔵 -5.95% | -0.38%p | ×0.6 | 🔻 개인 | -0.7억 | -0.7 | +0.0 | +0.0 | +0.0 | +0.7 | +0.0 |
| 2026-07-27 | 7,830 | 7,900 | 🔴 +0.89% | +1.78%p | ×0.3 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | -0.0 | +0.0 | +0.4 | +0.1 |
| 2026-07-24 | 7,860 | 7,830 | 🔵 -0.38% | +0.00%p | ×0.4 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-07-23 | 7,310 | 7,860 | 🔴 +7.52% | -0.41%p | ×0.8 | 🟢 외인 | +2.8억 | +2.8 | +0.0 | +0.0 | +0.0 | -2.8 | +0.0 |
| 2026-07-22 | 7,450 | 7,310 | 🔵 -1.88% | +0.00%p | ×0.7 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | -0.0 | +0.0 | +0.8 | +0.0 |
| 2026-07-21 | 7,750 | 7,450 | 🔵 -3.87% | -1.68%p | ×0.5 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | +0.3 | +0.0 | -1.2 | +0.0 |
| 2026-07-20 | 8,420 | 7,750 | 🔵 -7.96% | +2.02%p | ×0.9 | 🔻 개인 | -1.6억 | -1.6 | +0.0 | +0.3 | +0.0 | +1.2 | +0.0 |
| 2026-07-16 | 8,770 | 8,420 | 🔵 -3.99% | +1.60%p | ×0.6 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.0 | +0.9 | +0.0 |
| 2026-07-15 | 8,790 | 8,770 | 🔵 -0.23% | -0.57%p | ×0.4 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | -0.0 | +0.0 | -0.3 | +0.0 |
| 2026-07-14 | 9,160 | 8,790 | 🔵 -4.04% | +0.44%p | ×1.2 | 🔻 개인 | -2.7억 | -2.7 | +0.0 | +0.0 | +0.0 | +2.7 | +0.0 |
| 2026-07-13 | 9,220 | 9,160 | 🔵 -0.65% | +0.76%p | ×1.1 | ⚫ 그외 | -3.1억 | -3.1 | +0.0 | -0.0 | +0.0 | +0.9 | +2.2 |
| 2026-07-10 | 8,650 | 9,220 | 🔴 +6.59% | +0.81%p | ×0.7 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | +0.0 | +0.0 | -1.1 | +0.0 |
| 2026-07-09 | 8,370 | 8,650 | 🔴 +3.35% | -0.23%p | ×0.7 | 🟢 외인 | +1.7억 | +1.7 | +0.0 | +0.0 | +0.0 | -0.0 | -1.7 |
| 2026-07-08 | 9,160 | 8,370 | 🔵 -8.62% | -4.14%p | ×1.7 | 🔻 개인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | +3.1 | -3.2 |
| 2026-07-07 | 9,220 | 9,160 | 🔵 -0.65% | -0.32%p | ×1.0 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | +0.0 | -0.3 | -0.1 |
| 2026-07-06 | 9,390 | 9,220 | 🔵 -1.81% | +1.07%p | ×0.5 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.0 | +0.5 | +0.4 |
| 2026-07-03 | 9,420 | 9,390 | 🔴 +1.51% | +1.72%p | ×0.6 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | +0.0 | +0.0 | -0.8 | -0.2 |
| 2026-07-02 | 9,880 | 9,420 | 🔵 -4.66% | +1.72%p | ×0.5 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.6 | -0.3 |
| 2026-07-01 | 9,640 | 9,880 | 🔴 +2.49% | +0.42%p | ×0.4 | 🟢 외인 | +1.3억 | +0.9 | +0.0 | -0.0 | +0.4 | -1.3 | +0.1 |
| 2026-06-30 | 10,180 | 9,640 | 🔵 -5.30% | -1.08%p | ×0.4 | 🔻 개인 | -2.3억 | -2.3 | +0.0 | +0.0 | +0.0 | +2.3 | -0.1 |
| 2026-06-29 | 9,210 | 10,180 | 🔴 +10.53% | -0.65%p | ×0.9 | 🟢 외인 | +6.6억 | +6.6 | +0.0 | -0.1 | +0.0 | -6.5 | -0.0 |
| 2026-06-26 | 10,000 | 9,210 | 🔵 -7.90% | +1.30%p | ×1.1 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | -0.0 | +0.0 | -1.3 | -0.1 |
| 2026-06-25 | 10,300 | 10,000 | 🔵 -2.91% | +1.36%p | ×0.6 | 🔻 개인 | -1.8억 | -1.9 | +0.0 | -0.1 | +0.2 | +1.8 | +0.0 |
| 2026-06-24 | 10,000 | 10,300 | 🔴 +3.00% | -0.30%p | ×0.8 | 🟢 외인 | +6.0억 | +5.4 | +0.0 | +0.2 | +0.5 | -6.1 | -0.0 |
| 2026-06-23 | 10,590 | 10,000 | 🔵 -5.57% | -1.51%p | ×0.8 | 🟢 외인 | +5.9억 | +5.9 | +0.0 | -0.3 | -5.4 | -0.2 | |
| 2026-06-22 | 11,070 | 10,590 | 🔵 -4.34% | +0.09%p | ×0.5 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.0 | +0.5 | -0.1 | |
| 2026-06-19 | 11,670 | 11,070 | 🔵 -5.14% | -1.03%p | ×0.7 | 🔻 개인 | -2.3억 | -2.3 | +0.0 | +0.0 | +2.3 | +0.0 | |
| 2026-06-18 | 12,700 | 11,670 | 🔵 -8.11% | +0.08%p | ×0.4 | 🔻 개인 | -5.2억 | -5.2 | +0.0 | -0.2 | +5.4 | +0.0 | |
| 2026-06-17 | 11,640 | 12,700 | 🔴 +9.11% | +1.72%p | ×0.6 | 🟢 외인 | +4.3억 | +4.3 | +0.0 | +0.1 | -4.2 | -0.2 | |
| 2026-06-16 | 11,540 | 11,640 | 🔴 +0.87% | +0.44%p | ×1.0 | 🟢 외인 | +9.0억 | +9.0 | +0.0 | +0.2 | +2.2 | -11.5 | |
| 2026-06-15 | 11,470 | 11,540 | 🔴 +0.61% | +1.22%p | ×1.6 | 🔻 개인 | +7.8억 | +7.8 | +0.0 | +0.3 | +9.6 | -17.7 | |
| 2026-06-12 | 11,640 | 11,470 | 🔵 -1.46% | +0.86%p | ×1.4 | 🟢 외인 | +8.7억 | +8.7 | +0.0 | +0.4 | +4.2 | -13.3 | |
| 2026-06-11 | 11,370 | 11,640 | 🔴 +2.37% | +0.35%p | ×0.3 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | -0.0 | -0.2 | -0.2 | |
| 2026-06-10 | 11,400 | 11,370 | 🔵 -0.26% | -0.61%p | ×0.4 | 🟢 외인 | +1.9억 | +1.9 | +0.0 | +0.1 | -1.8 | -0.2 | |
| 2026-06-09 | 10,690 | 11,400 | 🔴 +6.64% | -0.47%p | ×0.5 | 🟢 외인 | +4.3억 | +4.3 | +0.0 | -0.1 | -4.0 | -0.1 | |
| 2026-06-08 | 11,900 | 10,690 | 🔵 -10.17% | -1.51%p | ×0.5 | 🟢 외인 | +3.4억 | +3.4 | +0.0 | -1.1 | -2.4 | +0.1 | |
| 2026-06-05 | 11,800 | 11,900 | 🔴 +0.85% | +0.68%p | ×0.6 | 🟢 외인 | +5.1억 | +5.1 | +0.0 | -0.2 | -4.7 | -0.2 | |
| 2026-06-04 | 12,130 | 11,800 | 🔵 -2.72% | -3.38%p | ×0.6 | 🟢 외인 | +1.6억 | +1.6 | +0.0 | +0.0 | -3.2 | +1.6 | |
| 2026-06-02 | 12,820 | 12,130 | 🔵 -5.38% | +0.24%p | ×1.7 | 🟢 외인 | +14.2억 | +14.2 | +0.0 | -0.1 | -9.7 | -4.4 | |
| 2026-06-01 | 15,140 | 12,820 | 🔵 -15.32% | -0.39%p | ×5.4 | 🟢 외인 | +28.5억 | +28.5 | +0.0 | +1.2 | -11.2 | -18.6 | |
| 2026-05-29 | 16,240 | 15,140 | 🔵 -6.77% | +0.25%p | ×1.2 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.4 | +0.8 | -0.1 | |
| 2026-05-28 | 16,710 | 16,240 | 🔵 -2.81% | -0.48%p | ×0.6 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | -0.2 | +0.2 | +0.1 | |
| 2026-05-27 | 16,870 | 16,710 | 🔵 -0.95% | +1.12%p | ×0.7 | 🟢 외인 | +5.0억 | +5.0 | +0.0 | -0.9 | -5.8 | +1.7 | |
| 2026-05-26 | 17,280 | 16,870 | 🔵 -2.37% | +0.41%p | ×0.7 | 🔻 개인 | -10.4억 | -10.4 | +0.0 | +0.0 | +10.7 | -0.3 | |
| 2026-05-22 | 15,580 | 17,280 | 🔴 +10.91% | +0.58%p | ×0.9 | 🟢 외인 | +14.8억 | +14.8 | +0.0 | +0.4 | -15.3 | +0.1 |
일자별 사유 (최신 위)
2026-08-04
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -1,616억)
- 매크로 원인: 코스닥 6%대 급반등 속 경영진 자사주 매입·임상데이터·기술이전 호재로 바이오 전반 강세 (보통)
2026-07-31
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +2,319억)
- 매크로 원인: 하반기 신약 임상·기술이전 기대감에 바이오 투자심리 회복, 개별 이슈 뒤섞인 종목별 급등 (보통)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +305억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)